Terlipressin versus other vasoactive drugs for hepatorenal syndrome

BACKGROUND: Hepatorenal syndrome is defined as severe renal failure occurring in people with cirrhosis and ascites. Systematic reviews of randomised clinical trials found that, compared with placebo, terlipressin may reduce mortality and improve renal function in people with hepatorenal syndrome, bu...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cochrane Database Syst Rev
Prif Awduron: Israelsen, Mads, Krag, Aleksander, Allegretti, Andrew S, Jovani, Manol, Goldin, Alison H, Winter, Rachel W, Gluud, Lise Lotte
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley & Sons, Ltd 2017
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6483765/
https://ncbi.nlm.nih.gov/pubmed/28953318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011532.pub2
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg